Blockade of CLEC5A not only attenuates lung inflammation and epithelial damage, but also it increases the efficacy of ciprofloxacin and prevents lung fibrosis caused by P. aeruginosa. This evidence concerns the gene CLEC5A and pulmonary fibrosis.